Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Non-Current Deffered Revenue (2016)

Historic Non-Current Deffered Revenue for Lisata Therapeutics (LSTA) over the last 4 years, with Q4 2016 value amounting to $4.6 million.

  • Lisata Therapeutics' Non-Current Deffered Revenue changed N/A to $4.6 million in Q4 2016 from the same period last year, while for Dec 2016 it was $4.6 million, marking a year-over-year change of. This contributed to the annual value of $4.6 million for FY2016, which is N/A changed from last year.
  • Latest data reveals that Lisata Therapeutics reported Non-Current Deffered Revenue of $4.6 million as of Q4 2016.
  • In the past 5 years, Lisata Therapeutics' Non-Current Deffered Revenue registered a high of $4.6 million during Q4 2016, and its lowest value of $143734.0 during Q3 2012.